Adenocarcinoma of the prostate is the most frequently diagnosed cancer and the second leading cause of cancer deaths among American men. Prostate cancer has an even more devastating impact on the ...

Agilent Technologies Inc. has introduced SurePrint G3 CGH+SNP cancer catalog microarrays, addressing the growing need of researchers to detect both copy number and copy-neutral aberrations in cancer ...

ANN ARBOR, Mich. – Of the approximately 35,000 genes in the human genome, scientists at the University of Michigan's Comprehensive Cancer Center have found that activity from just 67 is required to ...

Speaking of information access, consider the challenges of organizing content faced by microarray database designers. First, the amount of information on microarrays can be enormous. Second, each ...

The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile ...

Phase II prospective study on trabectedin (T) in BRCA-mutated and BRCAness phenotype advanced ovarian cancer (AOC) patients (pts): The MITO 15 trial.

Identification of hypoxanthine and phosphoenolpyruvic acid as serum markers associated with chemoradiotherapy response in locally advanced rectal cancer. This is an ASCO Meeting Abstract from the 2014 ...

Aushon BioSystems, Inc., has announced that the Department of Systems Biology at the MD Anderson Cancer Center has acquired another 2470 microarray printer from Aushon BioSystems. The new 2470 Arrayer ...

Scientific advances in the field of genetics and gene-expression profiling have revolutionized the concept of patient-tailored treatment. Analysis of differential gene-expression patterns across ...